rivastigmine has been researched along with olanzapine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hoefnagels, WH; Horstink, MW; Scheepmaker, AJ; Strijks, FE | 1 |
| Diraoui, S; Jansen, PA; van Melick, EJ | 1 |
| Arya, P; Butler, R; Warner, J | 1 |
| Mehalic, T; Noviasky, JA; Pacific, DM; Peltz, G; Shatla, A | 1 |
| Butler, R; Warner, J; Wuntakal, B | 1 |
| Bogetto, F; Marino, F; Montemagni, C; Perrone, D; Rocca, P | 1 |
| Lee, MR; Padua, Y; Stevens, DL | 1 |
| Leelavathi, M; Rosdinom, R; Suguna, M | 1 |
| Brown, J; Chan, BS; Downes, MA; Harris, K; Isoardi, KZ; Seebaluck, J | 1 |
3 review(s) available for rivastigmine and olanzapine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Dementia.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamine; Ginkgo biloba; Haloperidol; Humans; Indans; Memantine; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Risperidone; Rivastigmine; Selegiline; Tacrine; Vitamin E | 2004 |
Dementia.
Topics: Alzheimer Disease; Benzodiazepines; Dementia; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Memantine; Nootropic Agents; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Selegiline; Tacrine | 2005 |
8 other study(ies) available for rivastigmine and olanzapine
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Carbamates; Cholinesterase Inhibitors; Drug Therapy, Combination; Humans; Levodopa; Lewy Body Disease; Male; Neuroprotective Agents; Olanzapine; Phenylcarbamates; Pirenzepine; Risperidone; Rivastigmine; Treatment Outcome | 2003 |
[Clozapine for the treatment of psychosis in 3 elderly patients with Parkinson's disease].
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Humans; Male; Neuroprotective Agents; Olanzapine; Parkinson Disease; Phenylcarbamates; Psychotic Disorders; Rivastigmine; Treatment Outcome | 2004 |
Seizures associated with memantine use.
Topics: Aged; Benzodiazepines; Dopamine Agents; Drug Synergism; Female; Humans; Memantine; Neuroprotective Agents; Olanzapine; Phenylcarbamates; Rivastigmine; Seizures; Sertraline | 2005 |
Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Antipsychotic Agents; Behavior; Benzodiazepines; Cognition; Data Interpretation, Statistical; Dibenzothiazepines; Donepezil; Endpoint Determination; Female; Galantamine; Humans; Indans; Long-Term Care; Male; Neuropsychological Tests; Nootropic Agents; Olanzapine; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Retrospective Studies; Risperidone; Rivastigmine; Treatment Outcome | 2007 |
Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.
Topics: Antipsychotic Agents; Benzodiazepines; Cholinesterase Inhibitors; Dementia; Down Syndrome; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Phenylcarbamates; Rivastigmine | 2008 |
Pisa syndrome secondary to rivastigmine: a case report.
Topics: Aged; Benzodiazepines; Cholinesterase Inhibitors; Delusions; Dementia; Donepezil; Humans; Indans; Male; Movement Disorders; Olanzapine; Phenylcarbamates; Piperidines; Posture; Rivastigmine; Syndrome | 2012 |
Case series profile of olanzapine post-injection delirium/sedation syndrome.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Delirium; Female; Humans; Male; Middle Aged; Olanzapine; Physostigmine; Rivastigmine | 2023 |